According to Aytu BioScience
's latest financial reports the company has $19.52 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-06-30 | $22.98 M | 18.72% |
2022-06-30 | $19.36 M | -61.01% |
2021-06-30 | $49.64 M | 3.26% |
2020-06-30 | $48.08 M | 335.36% |
2019-06-30 | $11.04 M | 57.49% |
2018-06-30 | $7.01 M | 774.02% |
2017-06-30 | $0.8 M | -91.18% |
2016-06-30 | $9.09 M | 23.7% |
2015-06-30 | $7.35 M | 178.56% |
2014-08-31 | $0 M | 24.33% |
2014-06-30 | $2.63 M | |
2013-08-31 | $0 M | 1608.26% |
2012-08-31 | $0 M | -97.27% |
2011-08-31 | $0 M | 158.45% |
2010-08-31 | $0 M | -88.65% |
2009-08-31 | $0.01 M | -63.84% |
2008-08-31 | $0.03 M | 61.16% |
2007-08-31 | $0.02 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Rollins ROL | $0.11 B | 478.48% | ๐บ๐ธ USA |
Stride (K12 Education)
LRN | $0.37 B | 1,828.30% | ๐บ๐ธ USA |